These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21775886)

  • 21. Comparison of topical 0.3% ofloxacin to fortified tobramycin-cefazolin in the therapy of bacterial keratitis.
    Khokhar S; Sindhu N; Mirdha BR
    Infection; 2000; 28(3):149-52. PubMed ID: 10879638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluoroquinolones in the treatment of bacterial keratitis.
    Bower KS; Kowalski RP; Gordon YJ
    Am J Ophthalmol; 1996 Jun; 121(6):712-5. PubMed ID: 8644818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bilateral simultaneous Achromobacter xylosoxidans keratitis following penetrating keratoplasty.
    Srinivasan S; McAllum P; Poutanen SM; Slomovic AR
    J Cataract Refract Surg; 2006 Dec; 32(12):2149-52. PubMed ID: 17138001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cotrimoxazole-resistant Nocardia sclerokeratitis: effective therapy with fourth-generation fluoroquinolones.
    Mittal V; Fernandes M
    Can J Ophthalmol; 2012 Dec; 47(6):e58-60. PubMed ID: 23217523
    [No Abstract]   [Full Text] [Related]  

  • 25. Bilateral microbial keratitis in highly active antiretroviral therapy-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: a case series.
    Sachdev R; Bansal S; Sinha R; Sharma N; Titiyal JS
    Ocul Immunol Inflamm; 2011 Oct; 19(5):343-5. PubMed ID: 21834698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of fluoroquinolones against Mycobacterium abscessus in vivo.
    Caballero AR; Marquart ME; O'Callaghan RJ; Thibodeaux BA; Johnston KH; Dajcs JJ
    Curr Eye Res; 2006 Jan; 31(1):23-9. PubMed ID: 16421016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fourth-generation fluoroquinolone-resistant bacterial keratitis after refractive surgery.
    Moshirfar M; Mirzaian G; Feiz V; Kang PC
    J Cataract Refract Surg; 2006 Mar; 32(3):515-8. PubMed ID: 16631067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case of Vibrio vulnificus keratitis.
    You IC; Ahn M; Yoon KW; Yoon KC
    Jpn J Ophthalmol; 2008; 52(2):131-133. PubMed ID: 18626738
    [No Abstract]   [Full Text] [Related]  

  • 29. Gatifloxacin 0.3% Versus Fortified Tobramycin-Cefazolin in Treating Nonperforated Bacterial Corneal Ulcers: Randomized, Controlled Trial.
    Sharma N; Arora T; Jain V; Agarwal T; Jain R; Jain V; Yadav CP; Titiyal J; Satpathy G
    Cornea; 2016 Jan; 35(1):56-61. PubMed ID: 26509763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pseudomonas keratitis after laser in situ keratomileusis.
    Sharma N; Sinha R; Singhvi A; Tandon R
    J Cataract Refract Surg; 2006 Mar; 32(3):519-21. PubMed ID: 16631068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of besifloxacin, gatifloxacin, and moxifloxacin against strains of pseudomonas aeruginosa with different quinolone susceptibility patterns in a rabbit model of keratitis.
    Sanders ME; Moore QC; Norcross EW; Sanfilippo CM; Hesje CK; Shafiee A; Marquart ME
    Cornea; 2011 Jan; 30(1):83-90. PubMed ID: 20847656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacterial keratitis early after corneal crosslinking with riboflavin and ultraviolet-A.
    Pollhammer M; Cursiefen C
    J Cataract Refract Surg; 2009 Mar; 35(3):588-9. PubMed ID: 19251154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluoroquinolones or fortified antibiotics for treating bacterial keratitis: systematic review and meta-analysis of comparative studies.
    Hanet MS; Jamart J; Chaves AP
    Can J Ophthalmol; 2012 Dec; 47(6):493-9. PubMed ID: 23217502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical response of contact lens-associated fungal keratitis to topical fluoroquinolone therapy.
    Munir WM; Rosenfeld SI; Udell I; Miller D; Karp CL; Alfonso EC
    Cornea; 2007 Jun; 26(5):621-4. PubMed ID: 17525664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluoroquinolone therapy in a rabbit model of post-LASIK methicillin-resistant Staphylococcus aureus keratitis.
    Balzli CL; McCormick CC; Caballero AR; Huang B; Wigington L; Smith E; Tang A; O'Callaghan RJ
    J Cataract Refract Surg; 2008 Feb; 34(2):295-301. PubMed ID: 18242457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fourth-generation fluoroquinolone-resistant mycobacterial keratitis after laser in situ keratomileusis.
    Moshirfar M; Meyer JJ; Espandar L
    J Cataract Refract Surg; 2007 Nov; 33(11):1978-81. PubMed ID: 17964409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis.
    Ray KJ; Prajna L; Srinivasan M; Geetha M; Karpagam R; Glidden D; Oldenburg CE; Sun CQ; McLeod SD; Acharya NR; Lietman TM
    JAMA Ophthalmol; 2013 Mar; 131(3):310-3. PubMed ID: 23307105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Secondary bacterial keratitis associated with shield ulcer caused by vernal conjunctivitis.
    Gedik S; Akova YA; Gür S
    Cornea; 2006 Sep; 25(8):974-6. PubMed ID: 17102679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of the fourth-generation fluoroquinolones on corneal reepithelialization after penetrating keratoplasty.
    Sahu SK; Murthy SI; Sangwan VS; Thomas R
    Cornea; 2006 Oct; 25(9):1130; author reply 1130-1. PubMed ID: 17133074
    [No Abstract]   [Full Text] [Related]  

  • 40. The steroids for corneal ulcers trial (SCUT): secondary 12-month clinical outcomes of a randomized controlled trial.
    Srinivasan M; Mascarenhas J; Rajaraman R; Ravindran M; Lalitha P; O'Brien KS; Glidden DV; Ray KJ; Oldenburg CE; Zegans ME; Whitcher JP; McLeod SD; Porco TC; Lietman TM; Acharya NR;
    Am J Ophthalmol; 2014 Feb; 157(2):327-333.e3. PubMed ID: 24315294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.